Showing results (271-280 of 398) with videos related to

Sort By:
Pageof 40
Journal of Geriatric Oncology|January 26, 2017
A multi-center, open-label, randomized phase III trial of first-line chemotherapy with capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancerIn Gyu Hwang, Jun Ho Ji, Jung Hun Kang, et al.
BMC Cancer|April 11, 2009
A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancerSang Hoon Ji, Do Hyoung Lim, Seong Yoon Yi, et al.
The Journal of Urology|June 26, 2018
Changeable Conditional Survival Rates and Associated Prognosticators in Patients with Metastatic Renal Cell Carcinoma Receiving First Line Targeted TherapyMinyong Kang, Jae Young Park, Chang Wook Jeong, et al.
Cancer Research and Treatment|June 27, 2025
Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma in the East Asian Subgroup of the Phase 3 KEYNOTE-564 StudySe Hoon Park, Yen-Hwa Chang, Jae Lyun Lee, et al.
International Journal of Cancer|June 9, 2023
Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trialSun Young Rha, Toni K Choueiri, Vsevolod B Matveev, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 12, 2009
Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinomaJeeyun Lee, Won Ki Kang, Joon Oh Park, et al.
Plos One|November 6, 2014
High-throughput sequencing and copy number variation detection using formalin fixed embedded tissue in metastatic gastric cancerSeokhwi Kim, Jeeyun Lee, Min Eui Hong, et al.
Thoracic Cancer|April 5, 2016
Safety and efficacy of single-agent docetaxel (Taxotere) administered weekly in non-small cell lung carcinoma patients in Korea: An observational studySun Min Lim, Byeong Bae Park, Keun-Chil Park, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 5, 2019
A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancerTae-Yong Kim, Hye Sook Han, Keun-Wook Lee, et al.
Pathology, Research and Practice|January 23, 2020
TPK1 as a predictive marker for the anti-tumour effects of simvastatin in gastric cancerJung Yong Hong, Ha Jung Kim, Kyung Kim, et al.
Pageof 40